Background: Respiratory syncytial virus (RSV) is the predominant cause of lower respiratory tract infections (LRTI) in infancy. Preterm infants with bronchopulmonary dysplasia (BPD) are at the highest risk of severe RSV-LRTI. We report retrospectively a nosocomial outbreak of RSV-infections in the Neonatology of the University O&G hospital, Sofia.
Methods: Two groups of infants without contact between them were diagnosed with RSV-infection: 14 infants who were treated in the Department for healthy newborns, and 7 preterm infants, treated in the NICU. The detection of RSV was performed using Real-Time PCR in nasal/throat swabs.
Results: Respiratory symptoms occurred 2-5 days after discharge in 14 of 148 healthy term infants born from 5 to 18 February 2019; 12 babies were re-hospitalized with LRTI and recovered in a few days. In 6 infants the RSV-PCR was positive, in the others, RSV etiology was suggested due to similar symptoms and contact between them.
The first NICU-patient with RSV-LRTI was a 26 gestational weeks (GW) twin with BPD. From 19 February to 15 March 26 babies, 26-34 GW at birth were tested for RSV (33 nasal/throat swabs). They received a first or subsequent palivisumab-injection. We identified 11 positive samples in 7 of the babies. Six of them were with symptoms of LRTI, two needed mechanical ventilation. In 4 babies despite the recovery, the second RSV-PCR remained positive. After stabilization 6 babies were discharged home, one was transferred to the Paediatric department for further treatment of BPD.
Conclusions: The reported outbreak of RSV-infections in neonates was the most serious since the RSV-PCR diagnostic in Bulgaria was introduced. The course of RSV-LRTI was severe in extremely preterm newborns with underlying BPD. So routine in-hospital RSV-prophylaxis with palivizumab should be considered for infants at the highest risk.
Loading...
Posted 11 Jan, 2021
Posted 11 Jan, 2021
Background: Respiratory syncytial virus (RSV) is the predominant cause of lower respiratory tract infections (LRTI) in infancy. Preterm infants with bronchopulmonary dysplasia (BPD) are at the highest risk of severe RSV-LRTI. We report retrospectively a nosocomial outbreak of RSV-infections in the Neonatology of the University O&G hospital, Sofia.
Methods: Two groups of infants without contact between them were diagnosed with RSV-infection: 14 infants who were treated in the Department for healthy newborns, and 7 preterm infants, treated in the NICU. The detection of RSV was performed using Real-Time PCR in nasal/throat swabs.
Results: Respiratory symptoms occurred 2-5 days after discharge in 14 of 148 healthy term infants born from 5 to 18 February 2019; 12 babies were re-hospitalized with LRTI and recovered in a few days. In 6 infants the RSV-PCR was positive, in the others, RSV etiology was suggested due to similar symptoms and contact between them.
The first NICU-patient with RSV-LRTI was a 26 gestational weeks (GW) twin with BPD. From 19 February to 15 March 26 babies, 26-34 GW at birth were tested for RSV (33 nasal/throat swabs). They received a first or subsequent palivisumab-injection. We identified 11 positive samples in 7 of the babies. Six of them were with symptoms of LRTI, two needed mechanical ventilation. In 4 babies despite the recovery, the second RSV-PCR remained positive. After stabilization 6 babies were discharged home, one was transferred to the Paediatric department for further treatment of BPD.
Conclusions: The reported outbreak of RSV-infections in neonates was the most serious since the RSV-PCR diagnostic in Bulgaria was introduced. The course of RSV-LRTI was severe in extremely preterm newborns with underlying BPD. So routine in-hospital RSV-prophylaxis with palivizumab should be considered for infants at the highest risk.
Loading...